Next Article in Journal
Melanins in Fossil Animals: Is It Possible to Infer Life History Traits from the Coloration of Extinct Species?
Next Article in Special Issue
Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma
Previous Article in Journal
Lasiodiplodia theobromae as a Producer of Biotechnologically Relevant Enzymes
Previous Article in Special Issue
Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health
Open AccessArticle

Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro

1
Department of Gastroenterology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8641, Japan
2
Department of Advanced Medical Technology, Kanazawa University Graduate School of Health Medicine, Kanazawa 920-0942, Japan
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2018, 19(2), 108; https://doi.org/10.3390/ijms19020108
Received: 11 December 2017 / Revised: 10 January 2018 / Accepted: 17 January 2018 / Published: 23 January 2018
(This article belongs to the Special Issue Inflammation and Cancer 2018)
Hepatocellular carcinoma (HCC) frequently develops from hepatitis C virus (HCV) and hepatitis B virus (HBV) infection. We previously reported that peretinoin, an acyclic retinoid, inhibits HCV replication. This study aimed to examine the influence of peretinoin on the HBV lifecycle. HBV-DNA and covalently closed circular DNA (cccDNA) were evaluated by a qPCR method in HepG2.2.15 cells. Peretinoin significantly reduced the levels of intracellular HBV-DNA, nuclear cccDNA, and HBV transcript at a concentration that did not induce cytotoxicity. Conversely, other retinoids, such as 9-cis, 13-cis retinoic acid (RA), and all-trans-retinoic acid (ATRA), had no effect or rather increased HBV replication. Mechanistically, although peretinoin increased the expression of HBV-related transcription factors, as observed for other retinoids, peretinoin enhanced the binding of histone deacetylase 1 (HDAC1) to cccDNA in the nucleus and negatively regulated HBV transcription. Moreover, peretinoin significantly inhibited the expression of SPHK1, a potential inhibitor of HDAC activity, and might be involved in hepatic inflammation, fibrosis, and HCC. SPHK1 overexpression in cells cancelled the inhibition of HBV replication induced by peretinoin. This indicates that peretinoin activates HDAC1 and thereby suppresses HBV replication by inhibiting the sphingosine metabolic pathway. Therefore, peretinoin may be a novel therapeutic agent for HBV replication and chemoprevention against HCC. View Full-Text
Keywords: hepatitis B virus; acyclic retinoid; SPHK1; HDAC1 hepatitis B virus; acyclic retinoid; SPHK1; HDAC1
Show Figures

Figure 1

MDPI and ACS Style

Murai, K.; Shirasaki, T.; Honda, M.; Shimizu, R.; Shimakami, T.; Nakasho, S.; Shirasaki, N.; Okada, H.; Sakai, Y.; Yamashita, T.; Kaneko, S. Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro. Int. J. Mol. Sci. 2018, 19, 108.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop